These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15711991)

  • 81. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
    Lee JM; Choi KH; Lim BW; Kim MW; Kim J
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A Cadaveric Study of Dye Spreading: Determining the Ideal Injection Pattern for Masseter Hypertrophy.
    Sermswan P; Tansatit T; Meevassana J; Panchaprateep R
    Dermatol Surg; 2021 Oct; 47(10):1354-1358. PubMed ID: 34417381
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of unilateral injection of botulinum toxin on lower facial asymmetry as evaluated using three-dimensional laser scanning.
    Cha YR; Kim YG; Kim JH; Kim ST
    Dermatol Surg; 2013 Jun; 39(6):900-6. PubMed ID: 23506329
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Selective neurectomy of the masseteric nerve in masseter hypertrophy.
    Hwang K; Kim YJ; Park H; Chung IH
    J Craniofac Surg; 2004 Sep; 15(5):780-4. PubMed ID: 15346018
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Masseteric hypertrophy: considerations regarding treatment planning decisions and introduction of a novel surgical technique.
    Pary A; Pary K
    J Oral Maxillofac Surg; 2011 Mar; 69(3):944-9. PubMed ID: 21195532
    [No Abstract]   [Full Text] [Related]  

  • 86. Masseteric hypertrophy?: preliminary report.
    Newton JP; Cowpe JG; McClure IJ; Delday MI; Maltin CA
    Br J Oral Maxillofac Surg; 1999 Oct; 37(5):405-8. PubMed ID: 10577757
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect.
    Durand PD; Couto RA; Isakov R; Yoo DB; Azizzadeh B; Guyuron B; Zins JE
    Aesthet Surg J; 2016 Apr; 36(4):482-7. PubMed ID: 26780946
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bone and cartilage changes in rabbit mandibular condyles after 1 injection of botulinum toxin.
    Matthys T; Ho Dang HA; Rafferty KL; Herring SW
    Am J Orthod Dentofacial Orthop; 2015 Dec; 148(6):999-1009. PubMed ID: 26672706
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Diagnosis and therapy of masseter hypertrophy].
    Ott KH
    HNO; 1983 Jun; 31(6):207-11. PubMed ID: 6874434
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Painful unilateral temporalis muscle enlargement: reactive masticatory muscle hypertrophy.
    Katsetos CD; Bianchi MA; Jaffery F; Koutzaki S; Zarella M; Slater R
    Head Neck Pathol; 2014 Jun; 8(2):187-93. PubMed ID: 23900775
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy of Incobotulinum toxin-A for the treatment of masseter muscle hypertrophy in Asian Indian patients: A 2-year follow-up study.
    Shome D; Vadera S; Shiva Ram M; Kapoor R
    J Cosmet Dermatol; 2020 Aug; 19(8):1892-1899. PubMed ID: 32539203
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Phosphatidylcholine/deoxycholate lipolysis and hyaluronic acid augmentation to enhance nonsurgical lower facial contouring using botulinum toxin type A.
    Wong GR; Chen WP
    J Cosmet Dermatol; 2011 Jun; 10(2):159-62. PubMed ID: 21649822
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Masseter Muscle Volume Changes Evaluated by 3-Dimensional Computed Tomography After Repeated Botulinum Toxin A Injections in Patients With Square Facial Morphology.
    Chang CS; Lin S; Wallace CG; Hsiao YC; Lin CM; Kang GC; Chen ZC; Chen PK; Lo LJ; Chen YR; Chen JP
    Ann Plast Surg; 2019 Jan; 82(1S Suppl 1):S29-S32. PubMed ID: 30540604
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Hypertrophy of the masseter muscle. Clinical aspects--etiology--therapy].
    Abrams J
    Laryngorhinootologie; 1989 Jul; 68(7):383-7. PubMed ID: 2669773
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ultrasonic diagnosis of masseteric hypertrophy.
    Morse MH; Brown EF
    Dentomaxillofac Radiol; 1990 Feb; 19(1):18-20. PubMed ID: 2201578
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
    Terzis JK; Karypidis D
    J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intramuscular injection of botulinum toxin as an adjunct to total joint replacement in temporomandibular joint ankylosis: preliminary reports.
    Robiony M
    J Oral Maxillofac Surg; 2011 Jan; 69(1):280-4. PubMed ID: 21055863
    [No Abstract]   [Full Text] [Related]  

  • 99. Masseter muscle hypertrophy. Aetiology and therapy.
    Roncević R
    J Maxillofac Surg; 1986 Dec; 14(6):344-8. PubMed ID: 3467004
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Application of magnetic resonance imaging and ultrasonography to preoperative evaluation of masseteric hypertrophy.
    Sano K; Ninomiya H; Sekine J; Pe MB; Inokuchi T
    J Craniomaxillofac Surg; 1991 Jul; 19(5):223-6. PubMed ID: 1894741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.